Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Medical Genetics · SHORT Syndrome

The Physical and Metabolic Signs of SHORT Syndrome

At a Glance

SHORT syndrome can cause short stature, characteristic facial and eye findings, delayed teeth, reduced fat under the skin, and insulin resistance. Features vary between people, and monitoring blood sugar, liver health, and blood lipids remains important.

The symptoms of SHORT syndrome and related conditions are a unique blend of physical features and metabolic changes. While the name uses an acronym to describe common findings, it is important to remember that not everyone with a PIK3R1 mutation will have every symptom, and severity can vary greatly [1]. Medical teams often look for a “gestalt”—a overall pattern of features—to help make the diagnosis [2].

The SHORT Acronym

The term SHORT syndrome was originally created to help doctors remember five key features often seen together [1]:

  • S (Short Stature): Many individuals are born smaller than average (intrauterine growth restriction) and may continue to grow more slowly than their peers throughout childhood [2][3].
  • H (Hyperextensibility or Hernia): You may notice very flexible “double-jointed” limbs or a history of hernias, particularly in the groin (inguinal hernia) [1].
  • O (Ocular Depression): This refers to the physical appearance of the eyes, which may look deep-set [2].
  • R (Rieger Anomaly): Unlike ocular depression, which is about appearance, this is a structural change inside the eye [4]. It can involve an irregular pupil shape or a thin iris and may increase the risk of glaucoma (high pressure in the eye) or early cataracts in some individuals [4].
  • T (Teething Delay): Primary (baby) teeth and permanent teeth often arrive much later than expected [1]. Other dental signs can include smaller teeth (microdontia) or missing teeth [2].

Facial and Physical Appearance

Beyond the acronym, many individuals share a characteristic facial appearance. This often includes a triangular face shape, a prominent forehead (frontal bossing), and a small or recessed chin [2]. Because of the lack of fat under the skin, the face can sometimes have a “progeroid” or aged appearance, though this is not related to actual rapid aging and does not mean accelerated aging [1].

Lipoatrophy: A Unique Pattern of Fat Loss

In SHORT syndrome, the body has an impaired ability to develop and store fat, a condition called lipoatrophy [1]. This is often described as a form of partial lipodystrophy [5].

  • The fat loss is typically most noticeable in the face, arms, and legs [6].
  • The exact mechanisms of fat loss are complex and relate to impaired adipose tissue development [7].

Metabolic Symptoms and Insulin Resistance

The most significant internal symptom is insulin resistance. Because the cells process the insulin signal inefficiently, the body may produce much higher levels of the hormone to keep blood sugar stable [8].

  • Acanthosis Nigricans: You may see patches of dark, velvety skin, typically around the neck, armpits, or groin. This is a visible sign that insulin levels are high [9].
  • Diabetes Risk: The risk of developing diabetes is elevated, and age of onset varies; some individuals may maintain normal blood sugar for years, while others may require management earlier in life, particularly as insulin resistance increases during puberty [10].

A Different Metabolic Profile

If you have researched other types of lipodystrophy, you may have read about severe “fatty liver” or high fats (triglycerides) in the blood. SHORT syndrome is unique because it is often “liver-sparing” [8][11].

  • Patients often have less prominent liver fat [12].
  • Triglycerides and other blood lipids are often within the normal range [8].
    However, a normal triglyceride level or ultrasound does not rule out hepatic steatosis, and periodic monitoring of liver enzymes, lipids, and glucose is still required as clinically appropriate [12].

Common questions in this guide

What physical features are common in SHORT syndrome?
SHORT syndrome may involve short stature or growth restriction, flexible joints or a history of hernias, deep-set eyes, Rieger anomaly, and delayed teething. Facial features can include a triangular face, prominent forehead, and a small or recessed chin, but people can have different combinations and severity.
How does SHORT syndrome affect body fat and blood sugar?
The condition can cause partial loss of fat under the skin, especially in the face, arms, and legs. This may contribute to insulin resistance, dark velvety skin called acanthosis nigricans, and a higher risk of diabetes, particularly as insulin resistance increases during puberty.
What is the difference between ocular depression and Rieger anomaly in SHORT syndrome?
Ocular depression describes the appearance of deep-set eyes, while Rieger anomaly is a structural change inside the eye, such as an irregular pupil or thin iris. Rieger anomaly can increase the risk of glaucoma or early cataracts, so the healthcare team may recommend ophthalmology monitoring.
Does SHORT syndrome cause fatty liver or high triglycerides?
SHORT syndrome often has a liver-sparing metabolic pattern, with less prominent liver fat and triglyceride levels that may remain normal. Normal triglycerides or a normal ultrasound does not rule out fatty liver, so clinicians may still monitor liver enzymes, blood lipids, and glucose.
Will everyone with a PIK3R1 mutation have all the signs of SHORT syndrome?
No. People with SHORT syndrome can have different combinations and severity of features, and not everyone with a PIK3R1 mutation has every sign. Clinicians consider the overall pattern of physical and metabolic findings when evaluating the diagnosis.
How should diabetes risk be monitored in SHORT syndrome?
Insulin resistance may increase during puberty, although the timing and severity vary. A healthcare team can set a personalized schedule for checking blood sugar and may also monitor liver enzymes and blood lipids as clinically appropriate.

Get notified when new evidence is published on Lipodystrophy due to peptidic growth factors deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: toward recommendation for molecular testing and management.

    Avila M, Dyment DA, Sagen JV, et al.

    Clinical genetics 2016; (89(4)):501-506 doi:10.1111/cge.12688.

    PMID: 26497935
  2. 2

    SHORT Syndrome: Systematic Appraisal of the Medical and Dental Phenotype.

    Mubeen S, Gibson C, Mubeen R, et al.

    The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2022; (59(7)):873-881 doi:10.1177/10556656211026859.

    PMID: 34212753
  3. 3

    Transient Neonatal Diabetes Mellitus in SHORT Syndrome: A Case Report.

    Kim SH, Kim M, Yim J, et al.

    Frontiers in pediatrics 2021; (9()):650920 doi:10.3389/fped.2021.650920.

    PMID: 34249805
  4. 4

    Iris Malformation and Anterior Segment Dysgenesis in Mice and Humans With a Mutation in PI 3-Kinase.

    Solheim MH, Clermont AC, Winnay JN, et al.

    Investigative ophthalmology & visual science 2017; (58(7)):3100-3106 doi:10.1167/iovs.16-21347.

    PMID: 28632845
  5. 5

    SHORT Syndrome: an Update on Pathogenesis and Clinical Spectrum.

    Shvalb NF

    Current diabetes reports 2022; (22(12)):571-577 doi:10.1007/s11892-022-01495-8.

    PMID: 36401775
  6. 6

    SHORT syndrome in a two-year-old girl - case report.

    Klatka M, Rysz I, Kozyra K, et al.

    Italian journal of pediatrics 2017; (43(1)):44 doi:10.1186/s13052-017-0362-z.

    PMID: 28472977
  7. 7

    Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure.

    Kwok A, Zvetkova I, Virtue S, et al.

    Molecular metabolism 2020; (40()):101020 doi:10.1016/j.molmet.2020.101020.

    PMID: 32439336
  8. 8

    Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.

    Huang-Doran I, Tomlinson P, Payne F, et al.

    JCI insight 2016; (1(17)):e88766.

    PMID: 27766312
  9. 9

    Novel PIK3R1 gene mutation associated with SHORT syndrome: a case report of a 15-year-old female.

    Osman A, Morsi A, El-Refee S, Suliman S

    Journal of pediatric endocrinology & metabolism : JPEM 2024; (37(12)):1096-1099 doi:10.1515/jpem-2024-0244.

    PMID: 39258502
  10. 10

    Insulin resistant diabetes mellitus in SHORT syndrome: case report and literature review.

    Masunaga Y, Fujisawa Y, Muramatsu M, et al.

    Endocrine journal 2021; (68(1)):111-117 doi:10.1507/endocrj.EJ20-0291.

    PMID: 32879144
  11. 11

    Metreleptin In SHORT Syndrome With Uncontrolled Diabetes.

    Korakas E, Kountouri A, Ikonomidis I, et al.

    JCEM case reports 2025; (3(11)):luaf218 doi:10.1210/jcemcr/luaf218.

    PMID: 41080980
  12. 12

    The metabolically protective energy expenditure increase of Pik3r1-related insulin resistance is not explained by Ucp1-mediated thermogenesis.

    Luijten I, Onishi A, McKay EJ, et al.

    American journal of physiology. Endocrinology and metabolism 2025; (328(6)):E743-E755 doi:10.1152/ajpendo.00449.2024.

    PMID: 40152560

This page explains the physical and metabolic signs associated with SHORT syndrome for educational purposes. It does not replace medical advice; discuss genetic, eye, dental, and metabolic monitoring with your healthcare team.